Study guide

12.2 Acute Coronary Syndromes (ACS), STEMI Recognition & Pathophysiology

COPR Primary Care Paramedic PCP

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The COPR PCP Exam & How to Use This Guide

0.1 About the COPR PCP Entry-to-Practice Examination 0.2 The 2024 CPCF Blueprint: Competence Areas, Weights & Question Targets 0.3 Eligibility, Attempts, Accommodations & a 12-Week Study Plan

2 Chapter 1: Professionalism, Ethics & Legal Framework

1.1 Ethical Practice, Professionalism & Values in Canadian Paramedicine 1.2 Professional Accountability, Candour & Duty to Report 1.3 Regulatory Framework, Scope of Practice & Informed Consent

3 Chapter 2: Patient-Centred Communication & Clinical Documentation

2.1 Therapeutic Communication, Empathy & De-escalation 2.2 Patient-Centred Interviewing & Comprehensive History Gathering 2.3 Clinical Information Sharing, Consent & Incident Disclosure 2.4 Clinical Documentation, Electronic Health Records & Privacy 2.5 Shared Decision-Making, Health Literacy & Engaging Patients in Care Plans

4 Chapter 3: Interprofessional Collaboration & Continuum of Care

3.1 Care Team Roles, Task Delegation & Shared Decision-Making 3.2 Scene Collaboration, Interagency Conflict & Safety Culture 3.3 Safe Transfer of Care, Clinical Handover & Transition Plans

5 Chapter 4: Evidence-Informed Practice & Continuing Competence

4.1 Clinical Mentorship, Role Modelling & Reflective Debriefing 4.2 Evidence-Informed Practice, Guideline Translation & Lifelong Learning 4.3 Continuing Competence, Personal Learning Plans & Adapting to a Changing Profession

6 Chapter 5: Professional Health, Safety & Operational Resilience

5.1 Paramedic Wellness, Occupational Stress Injuries & PTSI Recognition 5.2 Fitness for Duty, Ergonomics, Safe Lifting & Peer Support Systems 5.3 Monitoring Personal Health, Healthy Coping & Removing Yourself from Practice

7 Chapter 6: Health Advocacy, Equity & Culturally Safe Care

6.1 Social Determinants of Health, Cultural Safety & Anti-Oppressive Practice 6.2 Anti-Indigenous Racism, Truth and Reconciliation & Trauma-Informed Care 6.3 System-Level Advocacy, Social Accountability & Working Toward Reconciliation

8 Chapter 7: Situational Leadership & Scene Operations

7.1 Prehospital Scene Assessment, Initial Incident Command & Hazard Mitigation 7.2 Clinical Resource Coordination & Practice Improvement Systems

9 Chapter 8: Infection Prevention, Diagnostics & Scene Preparedness

8.1 Infection Prevention and Control: Routine Practices, PPE & Sharps Safety 8.2 Point-of-Care Risk Assessment & Mass Casualty/CBRNE Principles 8.3 Paramedic Scope along the Continuum & Diagnostic Laboratory Correlation 8.4 Point-of-Care Risk Assessment, Situational Awareness & Securing Additional Resources

10 Chapter 9: Patient Assessment, Physical Examination & Vital Signs

9.1 Primary Survey, Rapid Trauma/Medical Exam & Threat Identification 9.2 Secondary Assessment, History Integration (SAMPLE/OPQRST) & Lifespan Adaptation 9.3 Vital Signs Interpretation, Glasgow Coma Scale & Clinical Reassessment

11 Chapter 10: Diagnostic Monitoring: ECG & Capnography

10.1 Prehospital Pulse Oximetry, Glucometry & Urinalysis 10.2 Prehospital Electrocardiography: 3-Lead Monitoring & 12-Lead Acquisition 10.3 Continuous Waveform Capnography (EtCO2) & Ventilation Dynamics

12 Chapter 11: Airway Management & Ventilation Therapeutics

11.1 Basic Airway Maneuvers, Positioning, OPA/NPA & Suctioning Techniques 11.2 Supraglottic Airway (SGA) Devices & Tracheostomy Management 11.3 Oxygen Delivery Modalities, Regulators & Safety 11.4 Positive Pressure Ventilation, BVM Mechanics, PEEP & CPAP 11.5 Foreign Body Airway Obstruction: Recognition & Relief Across the Lifespan 11.6 Beyond CPAP: BiPAP, High-Flow Nasal Cannula Therapy & Choosing a Ventilation Strategy

13 Chapter 12: Cardiovascular Emergencies & Resuscitative Care

12.1 High-Performance Cardiopulmonary Resuscitation (CPR) & Automated/Manual Defibrillation 12.2 Acute Coronary Syndromes (ACS), STEMI Recognition & Pathophysiology 12.3 Heart Failure, Cardiogenic Shock & Left Ventricular Assist Devices (LVAD) 12.4 Cardiovascular Pharmacotherapy: Nitroglycerin, ASA & Epinephrine

14 Chapter 13: Trauma Emergencies, Hemorrhage Control & SMR

13.1 External Hemorrhage Control: Tourniquets, Wound Packing & Pelvic Binders 13.2 Spinal Motion Restriction (SMR) & Canadian C-Spine Rule Application 13.3 Thoracic & Abdominal Trauma Management 13.4 Musculoskeletal Trauma, Fractures, Splinting & Dislocation Reduction 13.5 Head Injury & Traumatic Brain Injury: Preventing Secondary Brain Injury 13.6 Burns and Soft-Tissue Injury: Thermal, Chemical, Electrical & Inhalation

15 Chapter 14: Medical, Endocrine, Toxicological & Environmental Emergencies

14.1 Acute Respiratory Distress: Asthma, COPD, Pulmonary Edema & Anaphylaxis 14.2 Neurological Emergencies: Stroke Syndromes, TIA, Seizures & Status Epilepticus 14.3 Endocrine Emergencies: Hypoglycemia, DKA/HHS & Glucagon/Dextrose Administration 14.4 Toxicological Emergencies, Opioid Toxicity, Naloxone & Environmental Exposure 14.5 Abdominal, Gastrointestinal & Hepatobiliary Emergencies 14.6 Genitourinary, Renal & Dialysis Emergencies 14.7 Haematologic, Immunologic, EENT & Dental Emergencies

16 Chapter 15: Special Populations: Obstetrics & Neonatal Resuscitation

15.1 Antepartum Emergencies, Preeclampsia & Normal Spontaneous Childbirth 15.2 Complicated Deliveries: Breech, Prolapsed Cord, Nuchal Cord & Postpartum Hemorrhage 15.3 Neonatal Resuscitation Program (NRP) in the Prehospital Setting

17 Chapter 16: Special Populations: Pediatrics, Geriatrics, Palliative & Vulnerable Patients

16.1 Pediatric Assessment Triangle (PAT), Common Emergencies & Pediatric Dosing 16.2 Geriatric Syndromes, Polypharmacy, Elder Vulnerability & Falls 16.3 Palliative Emergencies, Medical Assistance in Dying (MAID) & Community Paramedicine 16.4 Bariatric Patients, Limited Mobility & Patients With Different Abilities

18 Chapter 17: Clinical Foundations — Terminology, Anatomy, Physiology & Pathophysiology

17.1 Medical & Paramedic Terminology, Abbreviations and Anatomical Reference 17.2 Applied Anatomy & Physiology Across Body Systems and the Lifespan 17.3 Core Pathophysiology: Cellular Injury, Hypoperfusion & the Shock States

19 Chapter 18: Pharmacology & Safe Medication Administration

18.1 Pharmacology Foundations: Classification, Pharmacokinetics & Pharmacodynamics 18.2 Safe Medication Administration: The Rights, Dose Calculation & Error Management 18.3 Medication Routes: Enteral, Parenteral, Inhaled & Topical Administration

20 Chapter 19: Vascular Access, Fluid Therapy, Routine Care & Patient Movement

19.1 Peripheral IV Cannulation, Venipuncture, Saline Locks & Maintaining Infusions 19.2 Intraosseous Access, Crystalloid Fluid Therapy, Pressure Infusers & Blood Products 19.3 Routine Care: Urinary Catheters, Ostomy & Drainage Systems, Chest Tubes & Wound Care 19.4 Patient Handling, Movement, Positioning & Transfer to a Higher Level of Care

21 Chapter 20: Mental Health, Behavioural Emergencies & Substance Use

20.1 Mental Status Assessment, Cognition & Capacity to Consent 20.2 Behavioural Emergencies, Severe Agitation & Safe Restraint 20.3 Substance Use, Addictions, Withdrawal & Harm Reduction

12.2 Acute Coronary Syndromes (ACS), STEMI Recognition & Pathophysiology

Key Takeaways Explain This Topic AI

Acute Coronary Syndromes (ACS) encompass an atherothrombotic continuum ranging from unstable angina (ischemia without biomarker release) and NSTEMI (subendocardial necrosis with elevated troponins) to STEMI (transmural necrosis caused by complete acute coronary occlusion).

Atypical presentations of myocardial ischemia—including isolated dyspnea, nausea, unexplained diaphoresis, syncope, or epigastric discomfort—frequently occur in female patients, older adults, and diabetic patients with autonomic neuropathy.

Contiguous lead groups localize anatomical infarction zones: Inferior (leads II, III, aVF / Right Coronary Artery [RCA]), Septal (V1, V2 / LAD), Anterior (V3, V4 / LAD), and Lateral (I, aVL, V5, V6 / Circumflex or diagonal LAD).

Right Ventricular Myocardial Infarction (RVMI) complicates up to 40% of inferior STEMIs; obtaining a right-sided ECG displaying ≥0.5–1 mm ST elevation in lead V4R confirms RV involvement and establishes a strict contraindication to nitrates and preload-reducing agents.

Prehospital STEMI bypass protocols mandate rapid acquisition and interpretation of a 12-lead ECG within 10 minutes of patient contact, direct notification to the regional PCI centre, and target medical contact-to-balloon times of <90–120 minutes.

Last updated: September 2026

  • 12.2 Acute Coronary Syndromes (ACS), STEMI Recognition & Pathophysiology
  • Atherothrombotic Pathophysiology & The Ischemic Spectrum

Acute Coronary Syndrome (ACS) describes an umbrella of acute life-threatening cardiovascular disorders triggered by sudden imbalance between myocardial oxygen demand and coronary arterial oxygen supply (CPCF Appendix A #2, #4). The primary underlying driver in >90% of ACS events is atherosclerotic plaque disruption :

Atherogenesis: Chronic endothelial injury from shear stress, hypertension, smoking, and dyslipidemia allows low-density lipoprotein (LDL) cholesterol to infiltrate the coronary intima. Macrophages engulf oxidized LDL, transforming into foam cells and establishing a lipid-rich necrotic core covered by a fragile fibrous cap.

Plaque Rupture or Erosion: Inflammatory matrix metalloproteinases degrade extracellular collagen within the fibrous cap. Hemodynamic turbulence causes mechanical fissuring, ulceration, or superficial endothelial erosion, exposing thrombogenic subendothelial collagen and von Willebrand factor to circulating platelets.

Platelet Activation & Thrombus Propagation: Platelets adhere to the exposed collagen via glycoprotein Ib-IX receptors, become activated, and release potent agonists: adenosine diphosphate (ADP), serotonin, and thromboxane A2 (TXA2) . The coagulation cascade is initiated, generating thrombin that converts fibrinogen into a stabilizing fibrin meshwork.

The Clinical Spectrum of ACS

Classification Pathophysiology & Occlusion Degree Biomarkers (Troponin I/T) Electrocardiographic Presentation

Unstable Angina (UA) Transient or non-occlusive mural thrombus; transient subendocardial ischemia without myocyte necrosis. Negative (no troponin elevation). Normal, transient ST depression, or dynamic T-wave inversion.

Non-ST-Elevation Myocardial Infarction (NSTEMI) Partially occlusive thrombus or severe microvascular embolization causing partial-thickness (subendocardial) necrosis. Elevated above 99th percentile URL. ST depression (≥0.5 mm), T-wave flattening or inversion, or non-diagnostic findings.

ST-Elevation Myocardial Infarction (STEMI) Acute, complete, and persistent epicardial coronary artery occlusion causing full-thickness ( transmural ) necrosis. Elevated (definitive laboratory elevation). Convex/horizontal ST elevation in ≥2 anatomically contiguous leads or new/presumed new LBBB.

Clinical Presentation: Classic Angina vs Atypical Presentations

Paramedics must distinguish classic retrosternal ischemic pain from atypical anginal equivalents:

Classic Anginal Symptoms: Heavy, crushing retrosternal pressure, squeezing, or tight fullness (often described by the patient clenching their fist over the sternum— Levine's sign ). Pain characteristically radiates to the left shoulder, left arm, neck, jaw, or interscapular region. Associated symptoms include diaphoresis, tachypnea, nausea, and a profound sense of impending doom.

Atypical Presentations ('Anginal Equivalents'): Absence of classic chest discomfort. Patients present with isolated, acute-onset symptoms such as unexplained dyspnea, extreme fatigue, nausea, vomiting, epigastric fullness, presyncope, syncope, or acute confusion.

High-Risk Demographics for Atypical ACS

Female Patients: Significantly more likely to present with dyspnea, nausea, jaw/back pain, and profound exhaustion without central chest pain. Female ACS is frequently characterized by coronary microvascular dysfunction and plaque erosion rather than large plaque ruptures.

Older Adults (Geriatrics ≥75 years): Often present with acute dyspnea, delirium, syncope, or generalized weakness. Age-related attenuation of pain perception and cognitive changes mask ischemic discomfort.

Diabetic Patients: Autonomic neuropathy damages cardiac sensory visceral afferent C-fibers, preventing the transmission of ischemic nociceptive impulses to the cerebral cortex. Myocardial infarction may occur as a completely 'silent' ischemic event or present with isolated autonomic instability.

Electrocardiographic Localization & Contiguous Lead Groups

Prehospital acquisition of a diagnostic 12-lead ECG is mandatory within 10 minutes of first medical contact (FMC) for any patient with suspected ACS or anginal equivalents. Electrocardiographic leads look at specific anatomical regions of the left and right ventricles supplied by distinct coronary arteries.

Diagnostic Criteria for STEMI

Under current Canadian and international consensus guidelines, STEMI is diagnosed by new ST-segment elevation measured at the J-point in at least two anatomically contiguous leads (leads viewing the same anatomical zone):

All Leads (Except V2–V3): ST elevation ≥1.0 mm (0.1 mV) .

Leads V2–V3:

  • Men <40 years: ≥2.5 mm (0.25 mV)
  • Men ≥40 years: ≥2.0 mm (0.2 mV)
  • Women (any age): ≥1.5 mm (0.15 mV)
  • Anatomical Correlation Table

Lead Group Anatomical Wall Viewed Primary Coronary Artery Involved Expected Reciprocal ST Depression

II, III, aVF Inferior Wall (diaphragmatic surface of LV) Right Coronary Artery (RCA) in 85–90% (or dominant Left Circumflex [LCx] in 10–15%). Leads I and aVL (high lateral).

V1, V2 Septal Wall (interventricular septum) Left Anterior Descending (LAD) artery (septal perforator branches). Rarely prominent; reciprocal changes variable.

V3, V4 Anterior Wall (anterior LV free wall) Left Anterior Descending (LAD) artery (diagonal branches). Leads II, III, aVF (inferior).

I, aVL, V5, V6 Lateral Wall (high lateral: I, aVL; low lateral: V5, V6) Left Circumflex (LCx) artery or diagonal branch of LAD. Leads II, III, aVF (inferior).

V1–V3 (Reciprocal) Posterior Wall (posterior basal LV) Left Circumflex (LCx) or distal RCA (posterior descending artery). Appears as ST depression and tall R waves in V1–V3; confirmed by ST elevation ≥0.5 mm in V7, V8, V9 .

Lead V4R Right Ventricle (right ventricular free wall) Proximal Right Coronary Artery (RCA) . Leads I and aVL.

Right Ventricular Myocardial Infarction (RVMI) & Lead V4R

Approximately 30% to 50% of acute inferior wall STEMIs involve the right ventricle, caused by acute proximal occlusion of the Right Coronary Artery (RCA) prior to the takeoff of the acute marginal branches.

Pathophysiological Dynamics of the Right Ventricle

The right ventricle is a thin-walled, highly compliant chamber designed to pump against low pulmonary vascular resistance. In acute RVMI, right ventricular contractile force collapses. The ischemic RV dilates, shifting the interventricular septum into the left ventricular cavity and severely impairing left ventricular diastolic filling. The patient becomes exquisitely preload-dependent : forward flow into the lungs and left heart relies almost entirely on passive venous filling pressures generated by high right atrial preload.

The Role of Lead V4R

Whenever ST elevation is identified in inferior leads (II, III, aVF), the paramedic must immediately acquire a right-sided 12-lead ECG , specifically observing lead V4R (placed in the right 5th intercostal space at the midclavicular line):

Diagnostic Threshold: ST-segment elevation ≥0.5 to 1.0 mm in lead V4R confirms acute Right Ventricular Infarction.

Triad of RVMI: Hypotension, clear lung fields (absence of pulmonary rales/crackles), and elevated Jugular Venous Distention (JVD).

Caution

Lethal Nitrate Contraindication in RVMI: Sublingual nitroglycerin, morphine, and diuretics induce systemic venodilation, pooling blood in peripheral capacitance vessels and collapsing right atrial venous return. In RVMI, administering nitrates leads to immediate catastrophic underfilling of the right ventricle, precipitous collapse of left ventricular stroke volume, and fatal cardiogenic shock. Nitrates are strictly contraindicated when V4R elevation or RV involvement is present.

  • Reciprocal ST-Segment Changes & Posterior Infarction
  • Clinical Significance of Reciprocal ST Depression

Reciprocal ST-segment depression represents an electrical mirror-image phenomenon. Surface ECG leads located directly opposite the ischemic injury vector view the electrical current of injury from the 'inside' or opposite side, registering ST depression. For example, acute inferior transmural injury directed toward leads II, III, and aVF produces reciprocal ST depression in leads I and aVL. The presence of reciprocal ST depression is the single most reliable discriminator distinguishing true acute STEMI from benign mimics like acute pericarditis (which exhibits diffuse ST elevation with PR depression and no reciprocal changes except in aVR).

True Posterior Myocardial Infarction

The standard 12-lead ECG does not directly interrogate the posterior basal wall of the left ventricle. Acute posterior transmural occlusion (typically LCx) projects mirror-image electrical changes onto anterior precordial leads (V1, V2, V3):

Horizontal ST-segment depression in V1–V3.

Tall, wide R waves (R/S ratio >1 in V2).

Upright, prominent T waves .

Confirmation: Paramedics must place posterior leads: V7 (posterior axillary line, 5th ICS), V8 (mid-scapular line, 5th ICS), and V9 (left paraspinal border, 5th ICS). ST elevation ≥0.5 mm in leads V7–V9 confirms acute posterior STEMI and triggers cath lab bypass activation.

Prehospital STEMI Systems of Care & Reperfusion Targets

Myocardial necrosis begins within 20 minutes of complete coronary occlusion and progresses from the subendocardium to the epicardium over 6 to 12 hours ( 'time is muscle' ). Prehospital paramedic identification directly shortens ischemic downtime.

Timelines and Bypass Protocols

First Medical Contact-to-ECG Time: Diagnostic 12-lead ECG acquired and interpreted within ≤10 minutes .

Primary Percutaneous Coronary Intervention (PCI) Bypass: If the patient meets regional STEMI criteria and transport time to a designated regional PCI facility is achievable within <90 to 120 minutes of First Medical Contact , the paramedic crew bypasses local non-PCI community hospitals to transport directly to the specialized cardiac catheterization suite.

Early Notification: Transmit the 12-lead ECG electronically or verbally activate 'Code STEMI' from the field to allow in-hospital interventional cardiology teams to mobilize prior to ambulance arrival.

Fibrinolytic Reperfusion Strategy: In remote or rural Canadian environments where transport time to a PCI center exceeds 120 minutes from FMC, prehospital clinicians assess for emergency fibrinolytic therapy (tenecteplase/TNK-tPA) with a target door-to-needle time of <30 minutes .

Clinical Scenario: STEMI Cath-Lab Bypass in an Atypical Presentation

A 68-year-old female with long-standing type 2 diabetes mellitus calls 911 for sudden-onset severe diaphoresis, acute nausea, and profound exhaustion that began 45 minutes prior while folding laundry. She denies any chest heaviness, pain, or shortness of breath.

Primary Assessment & High Index of Suspicion: The paramedic observes marked pallor, cool diaphoretic skin, BP 106/66 mmHg, HR 68 bpm, and RR 16/min. Recognizing that an older diabetic female presenting with acute autonomic symptoms represents an anginal equivalent, the crew acquires a 12-lead ECG at minute 6 of patient contact.

12-Lead Interpretation: The ECG demonstrates 2.5 mm ST elevation in leads II, III, and aVF with 2 mm reciprocal horizontal ST depression in leads I and aVL. The paramedic immediately recognizes an acute inferior STEMI .

Right-Sided Precordial Leads: Before formulating a pharmacotherapy plan, the crew acquires lead V4R, which reveals 1.5 mm of ST elevation. This confirms concurrent Right Ventricular Infarction .

Therapeutic Decision-Making:

ASA: 162 mg chewable acetylsalicylic acid is administered immediately.

Nitroglycerin: Strictly withheld due to confirmed RV involvement and profound risk of preload collapse.

Vascular Access & Fluids: An 18-gauge IV is established, and a 250 mL normal saline bolus is hung to ensure adequate right ventricular preload.

System Activation: The crew initiates prehospital STEMI cath-lab bypass, transmitting the ECG to the regional tertiary cardiac center 35 minutes away. The patient is transported directly to the cardiac catheterization laboratory, bypassing the emergency department, where a 100% proximal RCA occlusion is successfully revascularized.

Exam Pitfalls & High-Yield Diagnostic Pearls

Withholding 12-Lead in Atypical Presentations: Never exclude ACS based on the absence of chest pain. Always obtain a 12-lead in elderly, female, or diabetic patients with acute unexplained nausea, diaphoresis, syncope, or dyspnea.

Giving Nitrates Before Checking V4R in Inferior STEMI: Administering nitroglycerin to a patient with inferior STEMI before evaluating lead V4R can induce refractory, lethal cardiogenic shock.

Mistaking Posterior STEMI for Isolated Ischemia: Treating anterior ST depression in V1–V3 as simple non-specific subendocardial ischemia without checking posterior leads V7–V9 causes failure to activate STEMI bypass for true posterior transmural infarction.

Delaying Scene Time for Interventions: Prehospital STEMI management focuses on rapid acquisition of the ECG, ASA administration, and immediate transport; never delay scene departure to start secondary IV lines or perform non-essential procedures.